(HealthDay News) — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
20h
Lancashire Telegraph on MSNThese Lancashire towns are among places with highest number of takeawaysUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
A doctors’ union has welcomed plans by the Welsh Government to introduce restrictions on the promotion and placement of foods high in fat, salt and sugar.
The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results